Chloromycetin(CAP) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Chloromycetin(CAP) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-9-1 | 1. BSA-Chloromycetin(CAP) 2. Anti-Chloromycetin(CAP) mouse monoclonal antibody | $2709.00 |
GMP-SMT-9-2 | 1. OVA-Chloromycetin(CAP) 2. Anti-Chloromycetin(CAP) mouse monoclonal antibody | $2709.00 |
GMP-SMT-9-3 | 1. BSA-Chloromycetin(CAP) 2. Anti-Chloromycetin(CAP) human monoclonal antibody | $2709.00 |
GMP-SMT-9-4 | 1. OVA-Chloromycetin(CAP) 2. Anti-Chloromycetin(CAP) human monoclonal antibody | $2709.00 |
GMP-SMT-9-Ag-1 | BSA-Chloromycetin(CAP) | $756.00 |
GMP-SMT-9-Ag-2 | OVA-Chloromycetin(CAP) | $756.00 |
GMP-SMT-9-Ab-1 | Anti-Chloromycetin(CAP) mouse monoclonal antibody | $1953.00 |
GMP-SMT-9-Ab-2 | Anti-Chloromycetin(CAP) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Chloromycetin(CAP)
Cat No. | GMP-SMT-9-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Chloromycetin(CAP) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Chloromycetin(CAP) had been validated with our anti-Hapten antibody Anti-Chloromycetin(CAP) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Chloromycetin(CAP)
Cat No. | GMP-SMT-9-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Chloromycetin(CAP) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Chloromycetin(CAP) had been validated with our anti-Hapten antibody Anti-Chloromycetin(CAP) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Chloromycetin(CAP) mouse monoclonal antibody
Cat No. | GMP-SMT-9-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.2-0.3 |
Products description | The anti-Hapten antibody against hapten Chloromycetin(CAP) had been validated with our hapten hapten-carrier conjugates BSA-Chloromycetin(CAP) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Chloromycetin(CAP) human monoclonal antibody
Cat No. | GMP-SMT-9-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.2-0.3 |
Products description | The anti-Hapten antibody against hapten Chloromycetin(CAP) had been validated with our hapten hapten-carrier conjugates BSA-Chloromycetin(CAP) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
Florfenicol (FF) is a synthetic antibiotic that belongs to the phenicol class of antimicrobial agents. It has garnered significant attention and utility in veterinary medicine due to its potent bacteriostatic and bactericidal properties, which allow it to effectively combat a broad spectrum of Gram-negative bacteria and select Gram-positive bacteria. The multifaceted significance of Florfenicol in veterinary drug residues and additives can be comprehensively elucidated as follows:
a. Bacterial Infection Management: Florfenicol serves as a reliable and versatile tool in veterinary practice for addressing a range of bacterial infections in animals. Its efficacy extends to a variety of ailments, including respiratory tract infections, foot rot, and enteric diseases. As a bacteriostatic and bactericidal agent, Florfenicol helps in halting the growth of bacterial populations, thereby aiding in the resolution of infections.
b. Disease Control in Intensive Farming: In the context of intensive animal farming, where livestock is reared in high-density settings, the prevention and control of disease outbreaks are of paramount importance. Florfenicol plays a pivotal role in curbing the proliferation of bacterial infections among animals. By doing so, it helps in maintaining the health and well-being of the animals, which, in turn, ensures the economic stability of the industry.
c. Safe Antibiotic Alternative: Florfenicol has gained prominence as a safer alternative to certain antibiotics like chloramphenicol, which are prohibited for use in food-producing animals due to concerns related to human health. Florfenicol offers an effective means of treating animals while upholding the safety of food products. This is especially crucial in the context of ensuring that the food supply remains free from potentially harmful antibiotic residues.
d. Residue Compliance: Stringent regulations and safety standards mandate the monitoring of Florfenicol residues in animal tissues. This monitoring is essential to ensure compliance with regulatory requirements governing antibiotic residues in food-producing animals. It serves to verify that the levels of Florfenicol in animal tissues are within safe limits for human consumption. Proper management of these residues is indispensable to both regulatory compliance and food safety.
The measurement of Florfenicol (FF) holds pivotal importance for several critical objectives:
a. Residue Monitoring: Regular and accurate assessment of Florfenicol levels is imperative to verify the adherence of food products from treated animals to regulatory standards governing antibiotic residues. Such monitoring ensures that food products derived from treated animals are safe for human consumption. Failure to monitor and control antibiotic residues in food-producing animals could pose significant risks to public health.
b. Therapeutic Efficacy: Precise measurement of Florfenicol concentrations in the bloodstream of treated animals is not only beneficial but often essential. It facilitates the verification of effective treatment, ensuring that Florfenicol is present at therapeutic levels. This is crucial for the successful management of bacterial infections in animals. Furthermore, it aids veterinarians in making informed decisions about treatment regimens and adjustments.
c. Antibiotic Resistance Prevention: Routine measurement of Florfenicol levels is a proactive measure to prevent the emergence of antibiotic resistance. Overuse or improper administration of antibiotics can lead to the development of antibiotic-resistant bacterial strains. By monitoring Florfenicol levels, it is possible to ensure that the antibiotic is used judiciously, thereby mitigating the risk of resistance.
d. Quality Assurance: For biopharmaceutical entities, such as our company, engaged in the production of Florfenicol antibodies and competitive antigens, accurate measurement of Florfenicol levels is indispensable for quality control. This is crucial to guarantee the efficacy of our antibodies and antigens in detecting and quantifying Florfenicol in diverse applications. These applications include residue monitoring, scientific research, and diagnostic assays. The accuracy and reliability of the antibodies and antigens we provide are pivotal to the success of research and the safety of food products.
In summary, Florfenicol plays a prominent and multifaceted role in veterinary medicine and food safety. Its importance necessitates precise measurement for therapeutic, regulatory, and research purposes. Accurate Florfenicol measurements are crucial for ensuring the health and well-being of animals, the safety of food products, and the quality and reliability of diagnostic tools and research reagents associated with this antibiotic. The comprehensive understanding and management of Florfenicol are essential for safeguarding public health, ensuring animal welfare, and advancing scientific research in the realm of veterinary medicine.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.